XML 67 R55.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stockholders' Equity (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended 96 Months Ended
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2015
Dec. 31, 2023
Oct. 27, 2014
Stockholders' Equity                  
Balance, beginning of period $ 224,510,000 $ 227,483,000 $ 243,418,000 $ 244,900,000 $ 227,483,000 $ 244,900,000      
Common stock options exercised 5,000 20,000 2,000 (8,000)          
Investment in subsidiary with noncontrolling interest     306,000 203,000          
Investment in subsidiary with redeemable noncontrolling interest     (75,000) (36,000)          
Noncontrolling interest portion of Tongmei stock-based compensation (8,000) (11,000) 17,000 17,000          
Stock-based compensation 621,000 614,000 720,000 717,000          
Tongmei stock-based compensation 94,000 195,000 192,000 198,000          
Net loss (1,200,000) (1,977,000) (5,051,000) (3,517,000)          
Other comprehensive income (loss) (670,000) (1,814,000) (6,538,000) 928,000          
Balance, end of period 223,352,000 224,510,000 232,991,000 243,418,000 223,352,000 232,991,000   $ 227,483,000  
Net income (loss) attributable to redeemable noncontrolling interests (1,000)   (302,000)   (70,000) 451,000      
Other comprehensive loss attributable to redeemable noncontrolling interests 69,000   630,000   (258,000) 560,000      
Reclassification adjustment from AOCI $ 0   0   $ 0 0      
Stock repurchase program, authorized amount                 $ 5,000,000.0
Shares repurchased (in shares) 0       0   908,000 0  
Average price of shares repurchased (in dollars per share)             $ 2.52    
Total purchase price             $ 2,300,000    
Stock repurchase program remaining authorized repurchase amount $ 2,700,000       $ 2,700,000        
Preferred Stock                  
Stockholders' Equity                  
Balance, beginning of period 3,532,000 3,532,000 3,532,000 3,532,000 3,532,000 3,532,000      
Balance, end of period 3,532,000 3,532,000 3,532,000 3,532,000 3,532,000 3,532,000   $ 3,532,000  
Common Stock                  
Stockholders' Equity                  
Balance, beginning of period 44,000 44,000 44,000 44,000 44,000 44,000      
Balance, end of period 44,000 44,000 44,000 44,000 44,000 44,000   44,000  
Additional Paid-In Capital                  
Stockholders' Equity                  
Balance, beginning of period 239,257,000 238,452,000 236,192,000 235,308,000 238,452,000 235,308,000      
Common stock options exercised 5,000 20,000 2,000 (8,000)          
Investment in subsidiary with noncontrolling interest     (74,000) (36,000)          
Investment in subsidiary with redeemable noncontrolling interest     (75,000) (36,000)          
Noncontrolling interest portion of Tongmei stock-based compensation (15,000) (24,000) 31,000 33,000          
Stock-based compensation 621,000 614,000 720,000 717,000          
Tongmei stock-based compensation 94,000 195,000 192,000 198,000          
Balance, end of period 239,962,000 239,257,000 236,988,000 236,192,000 239,962,000 236,988,000   238,452,000  
Accumulated Deficit                  
Stockholders' Equity                  
Balance, beginning of period (34,123,000) (32,040,000) (17,507,000) (14,159,000) (32,040,000) (14,159,000)      
Net loss (1,516,000) (2,083,000) (5,089,000) (3,348,000)          
Balance, end of period (35,639,000) (34,123,000) (22,596,000) (17,507,000) (35,639,000) (22,596,000)   (32,040,000)  
Accumulated Other Comprehensive Income (Loss)                  
Stockholders' Equity                  
Balance, beginning of period (7,626,000) (5,999,000) (2,260,000) (3,118,000) (5,999,000) (3,118,000)      
Other comprehensive income (loss) (601,000) (1,627,000) (5,915,000) 858,000          
Balance, end of period (8,227,000) (7,626,000) (8,175,000) (2,260,000) (8,227,000) (8,175,000)   (5,999,000)  
AXT, Inc. Stockholders' Equity                  
Stockholders' Equity                  
Balance, beginning of period 201,084,000 203,989,000 220,001,000 221,607,000 203,989,000 221,607,000      
Common stock options exercised 5,000 20,000 2,000 (8,000)          
Investment in subsidiary with noncontrolling interest     (74,000) (36,000)          
Investment in subsidiary with redeemable noncontrolling interest     (75,000) (36,000)          
Noncontrolling interest portion of Tongmei stock-based compensation (15,000) (24,000) 31,000 33,000          
Stock-based compensation 621,000 614,000 720,000 717,000          
Tongmei stock-based compensation 94,000 195,000 192,000 198,000          
Net loss (1,516,000) (2,083,000) (5,089,000) (3,348,000)          
Other comprehensive income (loss) (601,000) (1,627,000) (5,915,000) 858,000          
Balance, end of period 199,672,000 201,084,000 209,793,000 220,001,000 199,672,000 209,793,000   203,989,000  
Noncontrolling Interests                  
Stockholders' Equity                  
Balance, beginning of period 23,426,000 23,494,000 23,417,000 23,293,000 23,494,000 23,293,000      
Investment in subsidiary with noncontrolling interest     380,000 239,000          
Noncontrolling interest portion of Tongmei stock-based compensation 7,000 13,000 (14,000) (16,000)          
Net loss 316,000 106,000 38,000 (169,000)          
Other comprehensive income (loss) (69,000) (187,000) (623,000) 70,000          
Balance, end of period $ 23,680,000 $ 23,426,000 $ 23,198,000 $ 23,417,000 $ 23,680,000 $ 23,198,000   $ 23,494,000